Triggering Receptor Expressed On Myeloid Cells 2 Variant Is Rare In Late-Onset Alzheimer'S Disease In Han Chinese Individuals

Jin-Tai Yu,Teng Jiang,Ying-Li Wang,Hui-Fu Wang,Wei Zhang,Nan Hu,Lin Tan,Lei Sun,Meng-Shan Tan,Xi-Chen Zhu,Lan Tan
DOI: https://doi.org/10.1016/j.neurobiolaging.2013.10.075
IF: 5.133
2014-01-01
Neurobiology of Aging
Abstract:Recent studies have reported that a rare mutation of triggering receptor expressed on myeloid cells 2 gene (TREM2 [rs75932628-T]) has significantly increased the risk of late-onset Alzhemier's disease (LOAD) in European-descendent population. To date, no study has investigated the association between rare mutations of TREM2 and LOAD risk in non-European population. Here, we sequenced exon2 of TREM2 in the northern Han Chinese population consisting of 1133 patients with LOAD and 1159 control subjects. Although, 4 novel mutations (c.102G>A: Val34Val, c.330C>T: Cys110Cys, c.342T>C: His114His, and c.343G>A: Gly115Ser) were identified in patients with LOAD, none of them exhibited significant association with LOAD risk after Bonferroni correction. Most importantly, the previously reported rare variants in European-descendent population including rs75932628-T (predicted to cause an R47H substitution) were absent in our cohort. These findings suggest that mutations in exon2 of TREM2 were unlikely to play a key role in the susceptibility of LOAD in the northern Han Chinese population. (C) 2014 Elsevier Inc. All rights reserved.
What problem does this paper attempt to address?